Esperion Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.

CEO

Sheldon L. Koenig

CEOSheldon L. Koenig

Employees

304

Employees304

Headquarters

Ann Arbor, Michigan

HeadquartersAnn Arbor, Michigan

Founded

1998

Founded1998

Employees

304

Employees304

ESPR Key Statistics

Market cap

182.15M

Market cap182.15M

Price-Earnings ratio

-3.30

Price-Earnings ratio-3.30

Dividend yield

—

Dividend yield—

Average volume

6.33M

Average volume6.33M

High today

$0.9498

High today$0.9498

Low today

$0.8519

Low today$0.8519

Open price

$0.88

Open price$0.88

Volume

4.84M

Volume4.84M

52 Week high

$3.94

52 Week high$3.94

52 Week low

$0.8191

52 Week low$0.8191

ESPR News

TipRanks 1d

Esperion’s Strategic Growth and Product Expansion Drive Buy Rating

Needham analyst Serge Belanger maintained a Buy rating on Esperion (ESPR – Research Report) today and set a price target of $5.00. Serge Belanger has given his...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

25%

Sell

12.5%